USA flag logo/image

An Official Website of the United States Government

SBIR TOPIC 255, PHASE I: DEVELOPMENT OF ANTICANCER VATPASE INHIBITORS

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
Program Year/Program:
2011 / SBIR
Agency Tracking Number:
N43CO110085
Solicitation Year:
2011
Solicitation Topic Code:
NCI
Solicitation Number:
Small Business Information
Omm Scientific, Inc
2600 N Stemmons Freeway, Suite 129 Dallas, TX 75207-2119
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2011
Title: SBIR TOPIC 255, PHASE I: DEVELOPMENT OF ANTICANCER VATPASE INHIBITORS
Agency: HHS
Contract: N43CO110085
Award Amount: $199,931.00
 

Abstract:

Invasive, metastatic, and/or drug resistant cancers are responsible for most cancer deaths. Development of a drug that blocks these phenotypes to improve outcomes is the ultimate objective. The specific means is by inhibiting the acidification of extra-cellular and extra-tumoral environments that otherwise facilitates invasion, metastasis, and drug resistance. The lead, RD203, potently inhibits the V-ATPase pump largely responsible for acidification and shows compelling anticancer activities. However, it requires continuous infusion for in vivo efficacy, an impediment to further development. Synthesis and testing of prod rugs of RD203 that mimic the exposure and compelling in vivo efficacy of continuous infusion is the challenging innovation and overall objective of this proposal. RD203 will be synthesized and used to prepare several types of each of three classes of prod rugs designed to release free RD203 slowly and/or target release at the tumor site. The modifications were selected for safety, develop-ability, and precedence in previous clinical development. The prodrugs will be screened and winnowed down by testing for useful: (a) chemical stability, (b) MTD, (c) desired pharmacokinetic profile, and (d) in vivo efficacy with daily doses. Fromthis process one or two RD203 prodrugs will be selected for further development. Provide

Principal Investigator:

Donald Stewart
214-350-9156
DSTEWART@OMMSCIENTIFIC.COM

Business Contact:

Donald Stewart
214-350-9156
DSTEWART@OMMSCIENTIFIC.COM
Small Business Information at Submission:

OMM SCIENTIFIC INC
2600 N STEMMONS FWY STE 129 DALLAS, TX 75207-2119

EIN/Tax ID: 593785219
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No